Monopar Therapeutics Inc. (MNPR) quarterly balance sheet — complete assets, liabilities & equity history
Monopar Therapeutics Inc. (MNPR) balance sheet — 11-year assets, liabilities & shareholders' equity history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Total Current Assets | 129.88M | 134.76M | 137.74M | 140.46M | 144.09M | 53.75M | 55.08M | 60.29M | 6.07M | 7.18M | 8.91M | 7.33M | 8.57M | 10.3M | 11.78M | 13.17M | 14.37M | 16.65M | 18.01M | 20.52M |
| Cash & Short-Term Investments | 129.45M | 134.3M | 137.49M | 140.4M | 143.68M | 53.25M | 54.55M | 60.21M | 6.02M | 7.12M | 8.79M | 7.27M | 8.49M | 10.19M | 11.68M | 13.12M | 14.32M | 16.46M | 17.82M | 20.3M |
| Cash Only | 52.63M | 52.76M | 52.54M | 61.83M | 127.68M | 39.5M | 39.71M | 45.82M | 6.02M | 6.12M | 7.81M | 7.27M | 5.52M | 7.21M | 5.73M | 8.19M | 14.32M | 16.46M | 17.82M | 20.3M |
| Short-Term Investments | 76.81M | 81.54M | 84.95M | 78.57M | 16M | 13.75M | 14.84M | 14.4M | 0 | 998.84K | 985.73K | 0 | 2.98M | 2.98M | 5.95M | 4.93M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 434.87K | 464.73K | 250.9K | 63.74K | 415K | 497.29K | 523.56K | 78.87K | 49.57K | 61.02K | 118.99K | 0 | 73.19K | 109.87K | 106.82K | 45.98K | 55.7K | 189.18K | 193.63K | 217.75K |
| Total Non-Current Assets | 366.72K | 215.12K | 239.88K | 254.92K | 107K | 118.17K | 9.1K | 0 | 0 | 0 | 0 | 12.65K | 25.09K | 37.33K | 49.38K | 61.23K | 72.89K | 84.36K | 53.69K | 0 |
| Property, Plant & Equipment | 366.72K | 215.12K | 239.88K | 254.92K | 106.67K | 118.17K | 9.1K | 0 | 0 | 0 | 0 | 12.65K | 25.09K | 37.33K | 49.38K | 61.23K | 72.89K | 84.36K | 53.69K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 334 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 130.25M | 134.98M | 137.98M | 140.72M | 144.2M | 53.87M | 55.09M | 60.29M | 6.07M | 7.18M | 8.91M | 7.35M | 8.59M | 10.34M | 11.83M | 13.23M | 14.45M | 16.74M | 18.07M | 20.52M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -9.67% | 150.58% | 150.49% | 133.4% | 2275.7% | 650.24% | 518.08% | 720.83% | -29.37% | -30.55% | -24.68% | -44.47% | -40.51% | -38.23% | -34.51% | -35.55% | -35.85% | -31.57% | -30.26% | 21.66% |
| Total Current Liabilities | 2.98M | 4.02M | 2.46M | 2.74M | 2.57M | 1.58M | 1.49M | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M | 1.98M | 2.5M | 2.89M | 3.13M | 1.91M | 2.19M | 1.07M | 1.58M |
| Accounts Payable | 2.82M | 4.02M | 2.46M | 2.74M | 2.54M | 1.58M | 1.49M | 2.25M | 1.12M | 1.09M | 1.44M | 1.76M | 1.98M | 2.5M | 2.89M | 3.13M | 1.91M | 2.19M | 1.07M | 1.58M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 43.55x | 33.56x | 56.04x | 51.35x | 56.10x | 33.94x | 36.92x | 11.47x | 5.41x | 6.59x | 6.21x | 4.17x | 4.32x | 4.12x | 4.08x | 4.21x | 7.51x | 7.61x | 16.77x | 12.98x |
| Quick Ratio | 43.55x | 33.56x | 56.04x | 51.35x | 56.10x | 33.94x | 36.92x | 11.47x | 5.41x | 6.59x | 6.21x | 4.17x | 4.32x | 4.12x | 4.08x | 4.21x | 7.51x | 7.61x | 16.77x | 12.98x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 199.81K | 107.83K | 131.56K | 154.92K | 71.45K | 80.37K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.41K | 20.85K | 33.09K | 25.34K | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 199.81K | 107.83K | 131.56K | 154.92K | 70.88K | 80.37K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.41K | 20.85K | 33.09K | 25.34K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 570 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.18M | 4.12M | 2.59M | 2.89M | 2.64M | 1.66M | 1.49M | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M | 1.98M | 2.5M | 2.89M | 3.14M | 1.94M | 2.22M | 1.1M | 1.58M |
| Total Debt | 357.26K | 107.83K | 131.56K | 154.92K | 102.24K | 80.37K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.41K | 20.85K | 33.09K | 25.34K | 0 |
| Net Debt | -52.28M | -52.65M | -52.41M | -61.68M | -127.57M | -39.42M | -39.71M | -45.82M | -6.02M | -6.12M | -7.81M | -7.27M | -5.52M | -7.21M | -5.73M | -8.18M | -14.3M | -16.43M | -17.79M | -20.3M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 127.07M | 130.85M | 135.39M | 137.83M | 141.56M | 52.2M | 53.59M | 55.04M | 4.95M | 6.09M | 7.48M | 5.59M | 6.61M | 7.84M | 8.94M | 10.09M | 12.51M | 14.52M | 16.97M | 18.94M |
| Equity Growth % | -10.24% | 150.67% | 152.63% | 150.43% | 2761.59% | 757.13% | 616.76% | 884.95% | -25.18% | -22.29% | -16.41% | -44.62% | -47.15% | -46.02% | -47.28% | -46.73% | -41.21% | -37.84% | -32.4% | 20.71% |
| Book Value per Share | 14.84 | 15.32 | 15.86 | 20.60 | 19.87 | 7.46 | 7.67 | 4.79 | 0.43 | 0.53 | 0.47 | 0.37 | 0.47 | 0.58 | 0.68 | 0.78 | 0.98 | 1.15 | 1.35 | 1.51 |
| Total Shareholders' Equity | 127.07M | 130.85M | 135.39M | 137.83M | 141.56M | 52.2M | 53.59M | 55.04M | 4.95M | 6.09M | 7.48M | 5.59M | 6.61M | 7.84M | 8.94M | 10.09M | 12.51M | 14.52M | 16.97M | 18.94M |
| Common Stock | 6.76K | 6.71K | 6.7K | 6.69K | 6.66K | 6.13K | 6.12K | 6.1K | 3.52K | 17.6K | 17.48K | 14.9K | 14.2K | 13.9K | 13.22K | 12.95K | 12.86K | 12.7K | 12.62K | 12.6K |
| Retained Earnings | -104.91M | -98.72M | -93.4M | -89.51M | -84.31M | -80.87M | -78.42M | -75.79M | -64.87M | -63.56M | -61.85M | -60.21M | -58.39M | -56.44M | -54.24M | -51.8M | -48.91M | -46.51M | -43.75M | -41.29M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 95.23K | 91.32K | 98.52K | 131.39K | 11.7K | 77.58K | -21.78K | 35.99K | -10.99K | 8.26K | 4.23K | -14.13K | 3.95K | 7.22K | 31.79K | 8.94K | 42.98K | 17.47K | -3.74K | -3.16K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |